Shire Bolsters its Haematology Business with US$325 M FerroKin BioSciences Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 20 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1702 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire has moved to strengthen its haematology franchise by agreeing to acquire FerroKin BioSciences for up to US$325 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS